Annual Total Liabilities
$656.51 M
+$62.30 M+10.49%
December 31, 2024
Summary
- As of March 10, 2025, APLS annual total liabilities is $656.51 million, with the most recent change of +$62.30 million (+10.49%) on December 31, 2024.
- During the last 3 years, APLS annual total liabilities has fallen by -$26.59 million (-3.89%).
- APLS annual total liabilities is now -13.16% below its all-time high of $756.01 million, reached on December 31, 2020.
Performance
APLS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$656.51 M
-$8.23 M-1.24%
December 31, 2024
Summary
- As of March 10, 2025, APLS quarterly total liabilities is $656.51 million, with the most recent change of -$8.23 million (-1.24%) on December 31, 2024.
- Over the past year, APLS quarterly total liabilities has stayed the same.
- APLS quarterly total liabilities is now -21.97% below its all-time high of $841.40 million, reached on June 30, 2021.
Performance
APLS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
APLS Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.5% | 0.0% |
| 3 y3 years | -3.9% | -3.9% |
| 5 y5 years | +84.9% | -3.9% |
APLS Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.9% | +11.2% | -4.0% | +16.1% |
| 5 y | 5-year | -13.2% | +84.9% | -22.0% | +84.9% |
| alltime | all time | -13.2% | >+9999.0% | -22.0% | >+9999.0% |
Apellis Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $656.51 M(+10.5%) | $656.51 M(-1.2%) |
| Sep 2024 | - | $664.75 M(+3.8%) |
| Jun 2024 | - | $640.15 M(+13.3%) |
| Mar 2024 | - | $565.25 M(-4.9%) |
| Dec 2023 | $594.21 M(+0.7%) | $594.21 M(+1.4%) |
| Sep 2023 | - | $585.95 M(+2.8%) |
| Jun 2023 | - | $570.17 M(+0.6%) |
| Mar 2023 | - | $566.75 M(-4.0%) |
| Dec 2022 | $590.35 M(-13.6%) | $590.35 M(+4.4%) |
| Sep 2022 | - | $565.48 M(-15.4%) |
| Jun 2022 | - | $668.08 M(-2.3%) |
| Mar 2022 | - | $683.62 M(+0.1%) |
| Dec 2021 | $683.10 M(-9.6%) | $683.10 M(+17.2%) |
| Sep 2021 | - | $583.01 M(-30.7%) |
| Jun 2021 | - | $841.40 M(+10.9%) |
| Mar 2021 | - | $758.47 M(+0.3%) |
| Dec 2020 | $756.01 M | $756.01 M(+14.1%) |
| Sep 2020 | - | $662.49 M(+3.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $638.04 M(+48.4%) |
| Mar 2020 | - | $429.94 M(+21.1%) |
| Dec 2019 | $355.02 M(+734.1%) | $355.02 M(+8.6%) |
| Sep 2019 | - | $326.80 M(+107.3%) |
| Jun 2019 | - | $157.62 M(+68.4%) |
| Mar 2019 | - | $93.60 M(+119.9%) |
| Dec 2018 | $42.56 M(+28.2%) | $42.56 M(-1.5%) |
| Sep 2018 | - | $43.19 M(+15.9%) |
| Jun 2018 | - | $37.27 M(+9.1%) |
| Mar 2018 | - | $34.16 M(+2.9%) |
| Dec 2017 | $33.19 M(+812.1%) | $33.19 M(+378.4%) |
| Sep 2017 | - | $6.94 M(-78.8%) |
| Jun 2017 | - | $32.69 M(+798.3%) |
| Dec 2016 | $3.64 M(+13.7%) | $3.64 M(+13.7%) |
| Dec 2015 | $3.20 M(+195.9%) | $3.20 M(+20.5%) |
| Sep 2015 | - | $2.66 M(+109.0%) |
| Jun 2015 | - | $1.27 M(+17.5%) |
| Dec 2014 | $1.08 M(+59.7%) | $1.08 M |
| Dec 2013 | $677.00 K | - |
FAQ
- What is Apellis Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual total liabilities year-on-year change?
- What is Apellis Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly total liabilities year-on-year change?
What is Apellis Pharmaceuticals annual total liabilities?
The current annual total liabilities of APLS is $656.51 M
What is the all time high annual total liabilities for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual total liabilities is $756.01 M
What is Apellis Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, APLS annual total liabilities has changed by +$62.30 M (+10.49%)
What is Apellis Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of APLS is $656.51 M
What is the all time high quarterly total liabilities for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly total liabilities is $841.40 M
What is Apellis Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, APLS quarterly total liabilities has changed by $0.00 (0.00%)